{"id":44162,"date":"2022-05-20T13:01:27","date_gmt":"2022-05-20T11:01:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/"},"modified":"2022-05-20T13:01:27","modified_gmt":"2022-05-20T11:01:27","slug":"ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/","title":{"rendered":"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences"},"content":{"rendered":"
\n

BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows:\n<\/p>\n

<\/a><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\nH.C. Wainwright Global Investment Conference (Virtual)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate:\n<\/p>\n<\/td>\n

\n

\nTuesday, May 24, 2022\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:\n<\/p>\n<\/td>\n

\n

\nOn Demand, 7:00 a.m. ET\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWebcast:\n<\/p>\n<\/td>\n

\n

\nClick Here<\/a>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nJefferies Healthcare Conference (New York City, NY)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate:\n<\/p>\n<\/td>\n

\n

\nThursday, June 9, 2022\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:\n<\/p>\n<\/td>\n

\n

\n11:30 a.m. ET\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWebcast:\n<\/p>\n<\/td>\n

\n

\nClick Here<\/a>\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nThe webcasts will be accessible via the Company\u2019s website at www.anipharmaceuticals.com<\/a>, in the Investors section under Events and Presentations.\n<\/p>\n

\nAbout ANI<\/b>\n<\/p>\n

\nANI Pharmaceuticals is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin\u00ae Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit www.anipharmaceuticals.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Lisa M. Wilson, In-Site Communications, Inc.
\n
T: 212-452-2793
\n
E: lwilson@insitecony.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows: H.C. Wainwright Global Investment Conference (Virtual) \u00a0 \u00a0 Date: Tuesday, May 24, 2022 \u00a0 \u00a0 Time: On Demand, 7:00 a.m. ET \u00a0 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44162","6":"format-standard","7":"category-industry"},"yoast_head":"\nANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows: H.C. Wainwright Global Investment Conference (Virtual) \u00a0 \u00a0 Date: Tuesday, May 24, 2022 \u00a0 \u00a0 Time: On Demand, 7:00 a.m. ET \u00a0 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-20T11:01:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220520005082\/en\/1306511\/21\/ANI_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences\",\"datePublished\":\"2022-05-20T11:01:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/\"},\"wordCount\":196,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220520005082\\\/en\\\/1306511\\\/21\\\/ANI_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/\",\"name\":\"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220520005082\\\/en\\\/1306511\\\/21\\\/ANI_logo.jpg\",\"datePublished\":\"2022-05-20T11:01:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220520005082\\\/en\\\/1306511\\\/21\\\/ANI_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220520005082\\\/en\\\/1306511\\\/21\\\/ANI_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences - Pharma Trend","og_description":"BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows: H.C. Wainwright Global Investment Conference (Virtual) \u00a0 \u00a0 Date: Tuesday, May 24, 2022 \u00a0 \u00a0 Time: On Demand, 7:00 a.m. ET \u00a0 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-20T11:01:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220520005082\/en\/1306511\/21\/ANI_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences","datePublished":"2022-05-20T11:01:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/"},"wordCount":196,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220520005082\/en\/1306511\/21\/ANI_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/","name":"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220520005082\/en\/1306511\/21\/ANI_logo.jpg","datePublished":"2022-05-20T11:01:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220520005082\/en\/1306511\/21\/ANI_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220520005082\/en\/1306511\/21\/ANI_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-present-at-upcoming-healthcare-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44162"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44162\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}